版本:
中国

BRIEF-Eiger updates progress in clinical development program

Nov 29 Eiger Biopharmaceuticals Inc :

* Eiger updates progress in clinical development program for exendin 9-39 to treat post-bariatric hypoglycemia (pbh)

* Eiger Biopharmaceuticals Inc - eiger has now filed an investigational new drug (ind) application for exendin 9-39 with fda Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐